SYNLOGIC, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
SYNLOGIC, INC. (SYBX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-03-12
- SYNLOGIC, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was 0.00 shares.
- SYNLOGIC, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- SYNLOGIC, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-03-31 was 44.70K shares, a 98.89% decline year-over-year.
- SYNLOGIC, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-09-30 was -4.13M shares, a 848.81% decline year-over-year.
- SYNLOGIC, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-03-12 | |||
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-12 | 44.70K shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 44.70K shares 10-Q · filed 2024-08-08 | ||
| 2024-03-31 | 44.70K shares 10-Q · filed 2024-05-14 | |||
| 2023-09-30 | -4.13M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -3.71M shares derived: sum of 2 quarters · filed 2023-11-09 | 303.81K shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 420.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 4.43M shares 10-Q · filed 2023-08-10 | ||
| 2023-03-31 | 4.01M shares 10-Q · filed 2023-05-11 | |||
| 2022-09-30 | 551.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 1.10M shares derived: sum of 2 quarters · filed 2022-11-10 | 3.44M shares 10-Q · filed 2022-11-10 | |
| 2022-06-30 | 546.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 2.89M shares 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | 2.34M shares 10-Q · filed 2022-05-12 | |||
| 2021-09-30 | 367.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 678.32K shares derived: sum of 2 quarters · filed 2021-11-10 | 2.01M shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 310.82K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 1.64M shares 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | 1.33M shares 10-Q · filed 2021-05-13 | |||
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | 0.00 shares 10-Q · filed 2017-08-04 | ||
| 2017-03-31 | 0.00 shares 10-Q · filed 2018-05-15 | |||
| 2016-09-30 | 263.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 542.00K shares derived: sum of 2 quarters · filed 2016-11-10 | 928.25K shares 10-Q · filed 2016-11-10 | |
| 2016-06-30 | 279.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | 665.25K shares 10-Q · filed 2016-08-15 | ||
| 2016-03-31 | 386.25K shares 10-Q · filed 2016-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |